Literature DB >> 20012000

[Principles of radiation therapy for malignant tumors of the orbit and the periorbital area].

T Kuhnt1, M Janich.   

Abstract

Primary malignant tumors of the orbit and the orbital adnexal area are rare, variform and in the majority of cases need an interdisciplinary treatment. According to tumor entity, tumor localization, and tumor extent the complete spectrum of radiotherapeutic therapy options is necessary. In the majority of malignant tumors, such as those of the eyelids, lachrymal glands, orbit, metastases, sarcoma or lymphoma, radiotherapy is used as a high energy therapy by means of medical linear accelerators as so-called teletherapy. In addition, new therapy methods, such as stereotactic highly conformal radiation or intensity-modulated radiation therapy (IMRT) were developed to achieve a higher local tumor control by a better configuration of the radiotherapy fields to the tumor borders and to contribute to a reduction of acute and chronic side effects in normal tissue by blurring of the dose. The application of ionizing radiation sources, such as so-called interstitial brachytherapy can also be just as carefully as effectively used. Particle beam radiotherapy is limited only to specially licensed centers and light hydrogen ions as proton therapy or carbon ions as heavy ion radiotherapy are in use. This overview will show the options as well as important progress in the field of radiotherapy in the treatment of tumors of the orbit and periorbital area.

Entities:  

Mesh:

Year:  2010        PMID: 20012000     DOI: 10.1007/s00106-009-2002-4

Source DB:  PubMed          Journal:  HNO        ISSN: 0017-6192            Impact factor:   1.284


  43 in total

1.  Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-Analysis of Chemotherapy on Head and Neck Cancer.

Authors:  J P Pignon; J Bourhis; C Domenge; L Designé
Journal:  Lancet       Date:  2000-03-18       Impact factor: 79.321

2.  A dosimetric comparison of non-coplanar IMRT versus Helical Tomotherapy for nasal cavity and paranasal sinus cancer.

Authors:  Ke Sheng; Janelle A Molloy; James M Larner; Paul W Read
Journal:  Radiother Oncol       Date:  2007-01-31       Impact factor: 6.280

3.  Perineural spread of cutaneous squamous cell carcinoma via the orbit. Clinical features and outcome in 21 cases.

Authors:  A A McNab; I C Francis; R Benger; J L Crompton
Journal:  Ophthalmology       Date:  1997-09       Impact factor: 12.079

4.  Malignant tumors of the nose and paranasal sinuses: hospital of the University of Pennsylvania experience 1990-1997.

Authors:  R P Tufano; N A Mokadam; K T Montone; G S Weinstein; A A Chalian; P F Wolf; R S Weber
Journal:  Am J Rhinol       Date:  1999 Mar-Apr

5.  Occurrence and prognosis of extranodal lymphomas.

Authors:  C Freeman; J W Berg; S J Cutler
Journal:  Cancer       Date:  1972-01       Impact factor: 6.860

6.  Defining risk levels in locally advanced head and neck cancers: a comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (# 9501).

Authors:  Jacques Bernier; Jay S Cooper; T F Pajak; M van Glabbeke; J Bourhis; Arlene Forastiere; Esat Mahmut Ozsahin; John R Jacobs; J Jassem; Kie-Kian Ang; J L Lefèbvre
Journal:  Head Neck       Date:  2005-10       Impact factor: 3.147

Review 7.  Intensity-modulated radiation therapy in head and neck cancers: an update.

Authors:  Nancy Lee; Dev R Puri; Angel I Blanco; K S Clifford Chao
Journal:  Head Neck       Date:  2007-04       Impact factor: 3.147

Review 8.  [Brachytherapy in combination with function-preserving surgery. An interdisciplinary challenge].

Authors:  J E Meyer; C Brocks; E Gehrking; G Kovács; B Neppert; J Gliemroth; B Wollenberg
Journal:  HNO       Date:  2008-04       Impact factor: 1.284

9.  Gamma knife radiosurgery for orbital tumors.

Authors:  Min-Su Kim; Kwan Park; Jong Hyun Kim; Yoon-Duck Kim; Jung-Il Lee
Journal:  Clin Neurol Neurosurg       Date:  2008-07-23       Impact factor: 1.876

10.  Phase II trial of a simultaneous radiochemotherapy with cisplatinum and paclitaxel in combination with hyperfractionated-accelerated radiotherapy in locally advanced head and neck tumors.

Authors:  Thomas Kuhnt; Axel Becker; Marc Bloching; Johannes Schubert; Gunther Klautke; Rainer Fietkau; Juergen Dunst
Journal:  Med Oncol       Date:  2006       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.